Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF) reported record sales for its fiscal second quarter, as it tries to narrow its losses after cancelling a merger in November.

The Canadian cannabis manufacturer posted C$13.4 million in gross revenue for the three months that ended Dec. 31, a 25% rise from the same period the previous year.

Still, net loss came out to C$121,718 for the quarter, which was a solid improvement from the C$772,616 loss reported in the same quarter last year.

The Ontario-based firm reported a 43% gross margin and positive adjusted EBITDA of C$356,828 for the quarter, showing some progress toward profitability.

“Ayurcann’s Q2 results reflect the strategic execution of our growth plan and solidify our position as a market leader in the Canadian cannabis space,” the company said in a news release.

The company, which focuses on extraction services and branded products, said it holds 6% of the Canadian vape market and 12% of Ontario’s vape market, positioning itself as a “top 3 producer of vapes in Ontario by volume,” citing data from cannabis analytics firm Hifyre IQ.

Ayurcann said it is on track to bring in more than C$50 million in revenue for fiscal 2025, which would be a 300% increase over the past three years; it reported annual revenue of C$11 million in fiscal 2022.

The company launched 30 new products in the last six months as it expanded across vapes, pre-rolls and cannabis extracts.

The results come just months after Ayurcann terminated its planned business combination with Arogo Capital Acquisition Corp. (NASDAQ: AOGO), a special purpose acquisition company. Ayurcann ended the deal, citing Arogo’s failure to meet stock exchange listing and public filing requirements, Green Market Report reported at the time.

Financials show the company’s working capital improved to C$3.6 million as of Dec. 31, versus a C$2.1 million deficit in June.

The Daily Hit is a recap of the top financial news stories for Thursday, November 21, 2024.

On the Site

Cannabis stocks up briefly Thursday before plunging on Gaetz withdrawal

The potential appointment of a pro-cannabis attorney general had boosted sentiment among cannabis investors.

Read more here.

Agrify gets $26M lifeline as GTI’s Kovler eyes extraction, hemp biz

Kovler has previously cited the GTI’s interest in Agrify’s extraction division.

Read more here.

Ayurcann terminates SPAC deal, citing regulatory filing failures

Arogo also initiated its own claim that the deal had been terminated, demanding the same $250,000 fee.

Read more here.

Earnings:

In Other News

Kentucky

Kentucky Gov. Andy Beshear announced Thursday that patients can start seeing doctors to get their written certifications for cannabis cards on Dec. 1.

Read more here.

Slang Worldwide

Highline Financial Group LLC has been named as the receiver of the assets, undertakings and property of certain Colorado subsidiaries of Slang Worldwide. The company also received a conditional extension of its waiver and support agreement.

Read more here.

Lifeist Wellness

Lifeist Wellness named Andrea Judge as chief executive officer, effective immediately. Judge has served as CEO of Lifeist’s subsidiary Mikra Cellular Sciences since July.

Read more here.